On August 5, 2011, MicroPort EP products, ColumbusTM 3D electrophysiological mapping system and VoyagerTM irrigated RF ablation catheter, recently completed the first-in-man clinical studies, have been unveiled in the 9th China Atrial Fibrillation Symposium (CAFS) through the case broadcast session. The experts gave their comments on the on-site procedure performed by Dr. Ronghui Yu of Beijing An Zhen Hospital. This is the first time MicroPort EP products have participated in the case broadcast at the national academic symposium. The results of which provide an excellent foundation for further large-scale clinical studies. MicroPort also organized a satellite session during the symposium which attracted attention from across the industry.